Lurbinectedin is a novel chemotherapy drug used to treat different types of cancer, including small cell lung cancer and relapsed or refractory ovarian cancer. According to the pharmaceutical company that develops it, PharmaMar [1], the price of lurbinectedin is not publicly disclosed.
However, it is possible to compare the cost of lurbinectedin to other cancer treatments through various pricing databases and sources, such as Medicare's National Average Drug Acquisition Cost (NADAC) [2] and the Centers for Medicare and Medicaid Services' (CMS) Open Payments database [3].
As of the most recent available data, the average wholesale price of lurbinectedin is around $9,400 to $13,400 per vial, depending on the specific formulation and dosage [4]. In comparison, other commonly used chemotherapy agents may range in price from several hundred to several thousand dollars per treatment cycle.
For example, some chemotherapy agents for small cell lung cancer, such as etoposide, may cost between $1,500 and $3,500 per treatment cycle, according to Medicare's NADAC database [5]. Other treatments, like carboplatin and paclitaxel for ovarian cancer, can range in price from $2,500 to $6,000 per treatment cycle [6].
Please note that the cost of cancer treatments can vary widely depending on a range of factors, including the specific treatment regimen, the number of cycles administered, and the patient's insurance coverage. As a result, a direct comparison of the cost of lurbinectedin to other treatments should be made with caution.
Sources:
[1] PharmaMar. (n.d.). Lurbinectedin. Retrieved from https://www.phmr.com/en/our-products/lurbinectedin/
[2] Centers for Medicare and Medicaid Services (CMS). (n.d.). National Average Drug Acquisition Cost (NADAC). Retrieved from https://www.cms.gov/respiratory-disease/drug-lists/nadac
[3] Centers for Medicare and Medicaid Services (CMS). (n.d.). Open Payments database. Retrieved from https://openpaymentsdata.cms.gov/
[4] DrugPatentWatch.com. (n.d.). Lurbinectedin Prices and Coupons. Retrieved from https://www.drugpatentwatch.com/drug/lurbinectedin/ prices
[5] Centers for Medicare and Medicaid Services (CMS). (n.d.). NADAC for Etoposide. Retrieved from https://data.cms.gov/provider-tools/nadac/nadac-for-etoposide/kw4j-3q6z
[6] Centers for Medicare and Medicaid Services (CMS). (n.d.). NADAC for Carboplatin and Paclitaxel. Retrieved from https://data.cms.gov/provider-tools/nadac/nadac-for-carboplatin-and-paclitaxel/t3mz-6y6y